HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis

NCT04571619 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

643

Enrollment

NIH

Sponsor class

Conditions

End Stage Renal Disease
Chronic Pain
Opioid Dependence

Interventions

BEHAVIORAL: Pain Coping Skills Training (PCST)
DRUG: Buprenorphine

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]